Altimmune, Inc.
Overview
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for liver disease, immune modulating therapies and vaccines. The company is known for its innovative approaches in developing therapies using immune modulation, which have significant potential in addressing various unmet medical needs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Altimmune, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
Dynavax Technologies Corporation
United States
Emergent BioSolutions Inc.
United States
FHI Clinical, Inc.
United States
Iliad Biotechnologies, LLC
United States
Merck & Co., Inc.
United States
Merck Sharp & Dohme LLC
United States
PathoVax Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.